Positron emission tomography imaging of meningioma in clinical practice: review of literature and future directions.

Neurochirurgische Klinik, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany.
Neurosurgery (Impact Factor: 2.53). 04/2012; 70(4):1033-41; discussion 1042. DOI: 10.1227/NEU.0b013e31823bcd87
Source: PubMed

ABSTRACT Meningiomas represent about 20% of intracranial tumors and are the most frequent nonglial primary brain tumors. Diagnosis is based on computed tomography (CT) and magnetic resonance imaging (MRI). Mainstays of therapy are surgery and radiotherapy. Adjuvant chemotherapy is tested in clinical trials of phase II. Patients are followed clinically by imaging. However, classical imaging modalities such as CT and MRI have limitations. Hence, we need supplementary imaging tools. Molecular imaging modalities, especially positron emission tomography (PET), represent promising new instruments that are able to characterize specific metabolic features. So far, these modalities have only been part of limited study protocols, and their impact on clinical routine management is still under investigation. It may be expected that their extended use will provide new aspects about meningioma imaging and biology. In the present article, we summarize PET imaging for meningiomas based on a thorough review of the literature. We discuss and illustrate the potential role of PET imaging in the clinical management of meningiomas. Finally, we indicate current limitations and outline directions for future research.

  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: About 90 % of meningiomas are benign (WHO grade I), atypical and anaplastic variants exist (WHO grade II/III, 10 %). Tumour grade has important implications for management. Non-invasive diagnosis of tumour grade is still not feasible. The purpose of this survey was to analyse epidemiological risk factors such as sex, age and location for a higher grade (WHO grade II/III) meningioma in a large surgical series. METHODS: A retrospective study comprising 1,663 patients operated on for an intracranial meningioma in a single tertiary-care centre. The population was analysed for correlations including WHO grade, histological subtype, tumour localisation, patient age and gender. Additionally correlations between Ki67 index/WHO grade and localisation were analysed. RESULTS: A binary logistic regression analysis revealed non-skull base localisation (OR 1.779 [CI 1.069-2.960, p = 0.0027]) and age ≥65 years (OR 1.549 [CI 1.214-2.624, p = 0.012]) as significant risk factors for a higher WHO grade. Male gender showed a trend for a higher risk in χ(2) analysis. An analysis of the Ki67 index revealed an increased index for non-skull base localisation compared with skull base (p < 0.001). Correlation analysis of Ki67 distribution in WHO grade I meningiomas revealed higher Ki67 indices for non skull base localisation (p = 0.0024). CONCLUSIONS: Non-skull base localisation and age ≥65 years are independent risk factors for higher grade meningiomas. In other terms, the malignant potential of skull base meningiomas is low. This information is important when advising a patient about individual treatment options (observation, surgery or radio-surgery) and prognosis.
    Acta Neurochirurgica 01/2013; · 1.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of a 75-year-old male patient treated with radiotherapy in 1999 for prostate cancer. Due to a rise in prostate-specific antigen, he underwent C-choline PET/CT. The study was negative for secondary lesions but revealed an incidental pathologic focal brain uptake. A subsequent magnetic resonance examination confirmed the presence of a brain lesion typical for meningioma.
    Clinical nuclear medicine 03/2013; · 3.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic resonance imaging (MRI) is the method of choice for the diagnosis of sphenoid wing meningiomas. The close relationship situation to vascular and neural structures especially at the skull base can best be assessed with MRI. With a typical configuration and extent the diagnosis of meningiomas can be made on visual examination and MRI is also the standard imaging technique for follow-up of treated and asymptomatic meningiomas. In the preoperative evaluation, computed tomography is a complementary examination technique which can demonstrate the extent and type of bone involvement more precisely. This additional information is important to differentiate meningiomas from differential diagnoses, such as metastases, sarcomas, and primary osseous changes, such as fibrous dysplasia or Paget's disease. Positron emission tomography computed tomography (PET-CT) and PET-MRI are also supplemental examination procedures which can be used for determining tumor volume before a planned radiotherapy and can be helpful in the diagnosis of atypical meningiomas due to the selective binding of the tracer DOTATOC. Conventional angiography is only rarely used preoperatively.
    Der Ophthalmologe 02/2013; · 0.53 Impact Factor